Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Details for Australian Patent Application No. 2009200257 (hide)

Owner Celgene Corporation

Inventors Jaworsky, Markian S.; Cameron, Louise M.; Muller, George W.; Saindane, Manohar T.; Chen, Roger Shen-Chu

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2009200257

Parent 2004270211

Filing date 23 January 2009

Wipo publication date 19 February 2009

Acceptance publication date 2 February 2012

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/454 (2006.01)

Event Publications

12 February 2009 Complete Application Filed

19 February 2009 Application Open to Public Inspection

  Published as AU-B-2009200257

2 February 2012 Application Accepted

  Published as AU-B-2009200257

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009200258-Methods of treating and/or suppressing weight gain

2009200256-Modulation of stem and progenitor cell differentiation, assays, and uses thereof